Literature DB >> 10163581

Full-cost determination of different levels of care in the intensive care unit. An activity-based costing approach.

J J Doyle1, J P Casciano, S R Arikian, J Mauskopf, J E Paul.   

Abstract

We applied an activity-based costing methodology to determine the full cost of intensive care service at a community hospital, a university hospital and a health maintenance organisation (HMO)-affiliated hospital. A total of 5 patient care units were analysed: the intensive care unit (ICU) and surgical ICU (SICU) at the university setting, the ICU at the community setting, and the SICU and cardiac care unit at the HMO setting. The selection of the different ICU types was based on the types of critical care units that were found in each setting (e.g. the HMO did not have an ICU). Institution-specific cost data and clinical management parameters were collected through surveys and site visits from the 3 respective organisation types. The analysis revealed a marked increase in patient-minute cost associated with mechanical ventilation. Higher costs associated with prolonged neuromuscular blockade have important economic implications with respect to selection of an appropriate neuromuscular blocking agent.

Entities:  

Mesh:

Year:  1996        PMID: 10163581     DOI: 10.2165/00019053-199610040-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  15 in total

1.  Prolonged weakness after long-term infusion of vecuronium bromide.

Authors:  Y Kupfer; T Namba; E Kaldawi; S Tessler
Journal:  Ann Intern Med       Date:  1992-09-15       Impact factor: 25.391

2.  Identifying drug usage patterns in the intensive care unit.

Authors:  H J Mann; E T Wittbrodt
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

Review 3.  Clinical pharmacokinetics of neuromuscular blocking drugs.

Authors:  S Agoston; R H Vandenbrom; J M Wierda
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 4.  Clinical pharmacology of the neuromuscular blocking agents.

Authors:  G E Larijani; I Gratz; M Silverberg; A G Jacobi
Journal:  DICP       Date:  1991-01

5.  The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.

Authors:  J M Wierda; U W Kleef; L M Lambalk; W D Kloppenburg; S Agoston
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 6.  The 'new' relaxants. A review of the clinical pharmacology of atracurium and vecuronium.

Authors:  T A Torda
Journal:  Anaesth Intensive Care       Date:  1987-02       Impact factor: 1.669

Review 7.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

8.  Prolonged neuromuscular blockade with atracurium.

Authors:  M D Bizzarri-Schmid; S P Desai
Journal:  Can Anaesth Soc J       Date:  1986-03

9.  Can ICUs be used more efficiently?

Authors:  R M Turley; S R Edwardson
Journal:  J Nurs Adm       Date:  1985 Jul-Aug       Impact factor: 1.737

10.  Patterns of resource consumption in medical intensive care.

Authors:  R K Oye; P E Bellamy
Journal:  Chest       Date:  1991-03       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.